MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation ROA Ratio 2011-2025 | HSKA
Annual ROA Ratio Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.4 | -0.19 | -3.6 | -0.6 | 3.74 | 7.33 | 8.03 | 4.77 | 2.69 | -1.28 | 1.8 | 3.47 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.03 | -3.6 | 1.9 |
Quarterly ROA Ratio Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.76 | -2.63 | -4.28 | -4.52 | -3.96 | -1.97 | -1.62 | -2.61 | -3.87 | -4.22 | -4.92 | -3.75 | -2.25 | -0.6 | 2.32 | 1.38 | 2.69 | 3.74 | 0.73 | 4.07 | 5.31 | 7.33 | 10.76 | 11.04 | 10.52 | 8.03 | 7.24 | 5.97 | 5.14 | 4.77 | 3.78 | 3.02 | 3.03 | 2.69 | 3.09 | 2.82 | -0.67 | -1.28 | -1.95 | -2.26 | 0.51 | 1.8 | 2.0 | 2.51 | 2.86 | 3.47 | 0.47 | 0.74 | 1.48 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.04 | -4.92 | 1.53 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 19.37 | - | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 21.18 | - | $ 228 M |  China |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 0.24 | - | $ 7.04 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 39.4 | - | $ 1.09 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
5.03 | $ 230.32 | - | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 10.04 | - | $ 285 M | Israel |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.52 | - | $ 1.93 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.57 | 0.03 % | $ 18.8 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
8.64 | $ 67.57 | - | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 26.72 | - | $ 808 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 19.48 | - | $ 1.05 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 102.25 | - | $ 4.03 B | USA |
 |
Anixa Biosciences
ANIX
|
-58.14 | $ 3.2 | - | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 226.92 | - | $ 41.1 B | USA |
 |
Guardant Health
GH
|
-29.37 | $ 102.98 | - | $ 12.6 B | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-12.39 | $ 6.48 | - | $ 587 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 5.08 | 1.8 % | $ 2.73 M | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 7.13 | -0.14 % | $ 1.55 B | USA |
 |
National Research Corporation
NRC
|
25.3 | $ 18.66 | - | $ 458 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 134.95 | - | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 203.66 | 0.25 % | $ 10.5 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 175.94 | - | $ 19.5 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 6.82 | - | $ 884 M | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 253.89 | -0.22 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.84 | -0.46 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 688.48 | - | $ 56.8 B | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 66.71 | - | $ 4.62 B | USA |
 |
Mettler-Toledo International
MTD
|
26.64 | $ 1 420.1 | 0.21 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
11.3 | $ 138.39 | - | $ 42.1 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.7 | - | $ 6.2 M | USA |
 |
Bioventus
BVS
|
-19.27 | $ 7.46 | 1.08 % | $ 467 M | USA |
 |
NeoGenomics
NEO
|
-4.81 | $ 12.28 | -0.16 % | $ 1.56 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 27.11 | - | $ 20 B |  Niderland |